Clinical Trials Details

E4512 ALCHEMIST- SUBSTUDY (Lung)

Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer

Objective

Crizotinib vs. Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein.

Clinical Trial Categories

  • Cancers and Other Neoplasms